Name | ML 315 hydrochloride |
---|---|
Synonyms |
MFCD30833328
5-(1,3-Benzodioxol-5-yl)-N-(3,5-dichlorobenzyl)-4-pyrimidinamine 4-Pyrimidinamine, 5-(1,3-benzodioxol-5-yl)-N-[(3,5-dichlorophenyl)methyl]- ML315 5-(1,3-Benzodioxol-5-yl)-N-[(3,5-dichlorophenyl)methyl]-4-pyrimidinamine hydrochloride |
Description | ML 315 is a selective dual inhibitor of CDK and DYRK with IC50s of 68 nM and 282 nM, respectively. ML 315 is used in cancer and neurological disease research[1]. |
---|---|
Related Catalog | |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 558.0±50.0 °C at 760 mmHg |
Molecular Formula | C18H13Cl2N3O2 |
Molecular Weight | 374.22 |
Flash Point | 291.2±30.1 °C |
Exact Mass | 373.038483 |
LogP | 5.10 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.682 |